IDO1 and neoplasm: Consistently, multicolor immunohistochemistry showed that the IDO1 inhibitor decreased the colocalization of CD31 with LC3 and TOMM20 in primary tumor tissues of the orthotopic OC mouse model (Fig. 9d).